About Finetech
Founded in 2007, Finetech is a high-tech enterprise focusing on the research and development, production and CDMO services of functional chemicals, KSMs, intermediates and APIs. Finetech has an exceptional level of scientific, regulatory, and project management knowledge gained through years of experience helping customers commercialize safe products. Our talented experts have the know-how, creativity and tenacity to solve even the most complex process challenges. Their ability to develop innovative solutions helps ensure success as you transition to commercial scale.
Established
company staff
Partners
Recommended products
Fast, phase-appropriate small molecule compound development and manufacturing
small molecule compound synthesis is a complex field requiring expertise in organic chemistry, process design, analytical chemistry, and regulatory compliance. At Finetech, our experts seamlessly integrate with your team, providing transparent insights and fast, phase-appropriate small molecule compound including KSMs, intermediates , APIs and Functional Chemicals development and manufacturing complying with GMP regulations to accelerate your path to market.
On December 12, 2024, the head and director of the chemical department of Toray Group visited Anhui Finetech Pharma Co.,Ltd. The main purpose of this high-level visit is to strengthen the strategic cooperation relationship between the two sides, clarify the future cooperation trends, and continue to create more cooperation and exchange opportunities on the existing basis.
During the meeting, the two sides made full exchanges on the company's overview, equipment and facilities, technology platform, quality system, superior products, concept and vision, and business development, and summarized the status of cooperation projects. The audits of these large pharmaceutical companies and high-quality customers have provided our company with valuable experience in learning and upgrading, and have provided great support and help for the further improvement and improvement of our quality system and the further opening of international and domestic markets.
We are committed to becoming a world-class supplier of intermediates and R&D services, with an unwavering dedication to quality, safety, and environmental responsibility.
◆ Hydrogenation and other high-pressure reactions (up to 10MPa)
◆ Low-temperature chemistry (down to –80°C)
◆ Drying (1 ton per batch)
◆ Distillation (up to 70 stages)
◆ High-temperature chemistry(up to 250°C)
◆Hydrogenation reaction
◆Amination reaction
◆diazoniation reaction
◆Grignard reaction
◆Asymmetric catalytic reduction reaction
◆Oxidation reaction
◆Bromination reaction
The local government strongly supports our GMP plant construction.
Fintech's cGMP plant will be put into use soon. the plant is around 50,000sqm, includes 4 multi-purpose plants, 1 hydrogenation plant, 100,000 class clean room, 1 6000sqm R&D building. the whole plant is disigned under cGMP guildline,provide RSM and pre-clinical API 's R&D and production service.
